Nomura (NMR) Downgraded to “Hold” at Zacks Investment Research

Nomura (NYSE:NMR) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research note issued on Saturday.

According to Zacks, “NOMURA HLDG-ADR is a leading financial services group in Japan and has worldwide operations, providing a wide range of value-added financial services and competitive products. These include brokerage, trading, underwriting, M&A financial advisory services, merchant banking, and development and management of investment trusts and investment advisory services to diversified clients such as individuals, corporations, financial institutions, governments and governmental agencies. “

How to Become a New Pot Stock Millionaire

Several other brokerages have also issued reports on NMR. Goldman Sachs upgraded Nomura from a “neutral” rating to a “buy” rating in a research note on Friday, January 19th. JPMorgan Chase & Co. upgraded Nomura from a “neutral” rating to an “overweight” rating in a research note on Friday, January 5th. One research analyst has rated the stock with a sell rating, two have issued a hold rating and three have given a buy rating to the company. The company has an average rating of “Hold” and a consensus price target of $6.75.

NMR stock opened at $5.68 on Friday. The company has a debt-to-equity ratio of 5.69, a current ratio of 1.00 and a quick ratio of 1.00. Nomura has a 1 year low of $5.28 and a 1 year high of $6.83. The firm has a market capitalization of $20,481.36, a price-to-earnings ratio of 8.88, a price-to-earnings-growth ratio of 5.74 and a beta of 1.78.

Nomura (NYSE:NMR) last posted its quarterly earnings data on Thursday, February 1st. The financial services provider reported $0.22 earnings per share for the quarter. Nomura had a return on equity of 8.79% and a net margin of 14.22%. The business had revenue of $4.70 billion for the quarter. equities analysts expect that Nomura will post 0.65 EPS for the current year.

Institutional investors and hedge funds have recently modified their holdings of the business. M&T Bank Corp bought a new stake in shares of Nomura in the fourth quarter valued at $347,000. Parametric Portfolio Associates LLC raised its stake in shares of Nomura by 2.9% in the third quarter. Parametric Portfolio Associates LLC now owns 2,729,998 shares of the financial services provider’s stock valued at $15,206,000 after buying an additional 76,685 shares during the period. Greenleaf Trust raised its stake in shares of Nomura by 46.0% in the fourth quarter. Greenleaf Trust now owns 34,278 shares of the financial services provider’s stock valued at $199,000 after buying an additional 10,798 shares during the period. Lourd Capital LLC bought a new stake in shares of Nomura in the fourth quarter valued at $436,000. Finally, Fisher Asset Management LLC raised its stake in shares of Nomura by 87.7% in the fourth quarter. Fisher Asset Management LLC now owns 8,108,584 shares of the financial services provider’s stock valued at $47,192,000 after buying an additional 3,788,844 shares during the period. Hedge funds and other institutional investors own 0.77% of the company’s stock.

TRADEMARK VIOLATION WARNING: “Nomura (NMR) Downgraded to “Hold” at Zacks Investment Research” was posted by Ticker Report and is the property of of Ticker Report. If you are reading this story on another domain, it was illegally stolen and republished in violation of US & international copyright & trademark laws. The legal version of this story can be read at https://www.tickerreport.com/banking-finance/3295279/nomura-nmr-downgraded-to-hold-at-zacks-investment-research.html.

Nomura Company Profile

Nomura Holdings, Inc (Nomura) is a financial services company. The Company, through its broker-dealer, banking and other financial services subsidiaries, provide investment, financing and related services to individual, institutional and government clients across the world. The Company’s segments include Retail, Asset Management and Wholesale.

Get a free copy of the Zacks research report on Nomura (NMR)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Nomura Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nomura and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

The Graham Holdings Company  Shares Sold by TIAA CREF Investment Management LLC
The Graham Holdings Company Shares Sold by TIAA CREF Investment Management LLC
Taylor Cottrill Erickson & Associates Inc. Sells 847 Shares of Apple
Taylor Cottrill Erickson & Associates Inc. Sells 847 Shares of Apple
Glacier Bancorp  Given Consensus Recommendation of “Hold” by Analysts
Glacier Bancorp Given Consensus Recommendation of “Hold” by Analysts
Teachers Advisors LLC Acquires 6,478 Shares of Kala Pharmaceuticals
Teachers Advisors LLC Acquires 6,478 Shares of Kala Pharmaceuticals
TIAA CREF Investment Management LLC Has $559.74 Million Position in Amgen
TIAA CREF Investment Management LLC Has $559.74 Million Position in Amgen
Teachers Advisors LLC Takes $332,000 Position in Deciphera Pharmaceuticals
Teachers Advisors LLC Takes $332,000 Position in Deciphera Pharmaceuticals


© 2006-2018 Ticker Report. Google+.